Doctor in the House: Biosimilar Drugs – Making Cancer Treatment Affordable

from Health & Living · host BFM Media

Dr George Lee returns to discuss the latest medical news. Expect deep insights delivered with generous humour. Earlier this week, the Health Ministry announced  that it has approved the biosimilar version of trastuzumab, a targeted therapy for women with HER2-positive breast cancer. The biosimilar version will significantly reduce the cost of treatment, which currently costs RM130,000 a year. Datin Paduka Prof Dr Teo Soo Hwang, CEO of Cancer Research Malaysia, joins us to discuss how biosimilar therapies can improve accessibility to cancer care.See omnystudio.com/listener for privacy information.

NOW PLAYING

0:00 47:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Health & Living?

This episode is 47 minutes long.

When was this Health & Living episode published?

This episode was published on December 14, 2018.

What is this episode about?

Can I download this Health & Living episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!